Search Results
You are looking at 1 - 4 of 4 items for
- Author: S R Bloom x
- Refine by access: All content x
Search for other papers by D. Bretherton-Watt in
Google Scholar
PubMed
Search for other papers by M. A. Ghatei in
Google Scholar
PubMed
Search for other papers by S. Legon in
Google Scholar
PubMed
Search for other papers by H. Jamal in
Google Scholar
PubMed
Search for other papers by K. Suda in
Google Scholar
PubMed
Search for other papers by S. R. Bloom in
Google Scholar
PubMed
ABSTRACT
Islet amyloid polypeptide (IAPP) in the pancreas of the spontaneously diabetic (BB) Wistar rat was examined by radioimmunoassay, and IAPP mRNA levels were determined by Northern blotting. IAPP-like immunoreactivity in the diabetic rat pancreas was found to be significantly depleted compared with control (non-diabetic) BB rats (85·9±5 pmol/g in control rats, n = 8, vs 8·97 ± 0·9 pmol/g in diabetic rats, n=5; mean ± s.e.m.). A similar change in insulin concentrations was found, although insulin was present in approximately 100-fold greater amounts than IAPP. Chromatography of the IAPP immunoreactivity revealed a single molecular form, corresponding to synthetic IAPP. Northern blot analysis of pancreatic RNA (n = 4) revealed that IAPP mRNA in the diabetic group was depleted to 22% of the signal intensity in the control group. Insulin mRNA was dramatically reduced to only 4% of the control group and, in contrast, somatostatin was relatively unaffected, with the diabetic group retaining 86% of signal compared with the controls.
This animal model of insulin-dependent diabetes results from severe autoimmune destruction of the β cell. The extremely low levels of both insulin and its messenger RNA are in agreement with this. These results demonstrate that this pathological state is also associated with a loss of IAPP from the pancreas. Insulin-dependent diabetes is associated with a range of metabolic disturbances. It is possible that the concomitant depletion of IAPP may be a contributory factor in exacerbating the condition.
Search for other papers by C Austin in
Google Scholar
PubMed
Search for other papers by G Lo in
Google Scholar
PubMed
Search for other papers by K A Nandha in
Google Scholar
PubMed
Search for other papers by L Meleagros in
Google Scholar
PubMed
Search for other papers by S R Bloom in
Google Scholar
PubMed
ABSTRACT
Many peptide precursors encode more than one bioactive peptide. Recent cloning of the rat neuromedin U (NmU) precursor revealed potential proteolytic processing sites which may generate three associated peptides in addition to the NmU peptide, which is known to have potent uterine contractile effects. To assess the degree of evolutionary conservation, which often suggests conserved biological function and hence physiological importance, we have cloned and sequenced the cDNA encoding the human NmU precursor. Sequence analysis revealed a 174 amino acid human precursor containing the 25 residue NmU peptide near the C terminus of the precursor. The human message sequence was 74% homologous with that of the rat, indicating evolutionary conservation of the precursor between these two species. Four out of five of the putative proteolytic processing sites, first revealed in the rat precursor, were conserved in the human precursor, indicating a similar processing mechanism in both species. Two such processing sites flank a 33 residue peptide sequence which differed in only two amino acids compared with the rat homologue. This conservation suggests a possible biological role for this putative peptide.
Northern blot analysis of human gastrointestinal tissues revealed a similar level of mRNA throughout the gastrointestinal tract. RIA using a porcine specific assay showed the highest levels of peptide in the jejunum samples.
Search for other papers by G J M Ferrier in
Google Scholar
PubMed
Search for other papers by A M Pierson in
Google Scholar
PubMed
Search for other papers by P M Jones in
Google Scholar
PubMed
Search for other papers by S R Bloom in
Google Scholar
PubMed
Search for other papers by S I Girgis in
Google Scholar
PubMed
Search for other papers by S Legon in
Google Scholar
PubMed
ABSTRACT
We have used the polymerase chain reaction with mixed sequence primers to generate a probe for rat amylin and have used this to detect expression in various rat tissues. Amylin mRNA is found in greatest concentrations in the pancreas where a single mRNA species can be detected giving a hybridisation signal intensity approximately 10% that of insulin mRNA. When the beta cell population was depleted with streptozotocin, both amylin and insulin mRNAs were reduced to a similar extent. Consistent with its supposed role in the control of carbohydrate metabolism, amylin mRNA was also found in the stomach. Unlike the related peptide, CGRP, amylin mRNA is not present in the thyroid and is not widely distributed in the central nervous system. The only nervous tissue in which it could be detected was the dorsal root ganglion. Surprisingly, amylin mRNA was also found in the lung though only at very low levels.
Search for other papers by C Austin in
Google Scholar
PubMed
Search for other papers by M Oka in
Google Scholar
PubMed
Search for other papers by K A Nandha in
Google Scholar
PubMed
Search for other papers by S Legon in
Google Scholar
PubMed
Search for other papers by N Khandan-Nia in
Google Scholar
PubMed
Search for other papers by G Lo in
Google Scholar
PubMed
Search for other papers by S R Bloom in
Google Scholar
PubMed
ABSTRACT
This study has quantified, for the first time, the relative levels of neuromedin U (NmU) mRNA in the rat gastrointestinal tract using Northern blot analysis. NmU message was detected in all regions of the gastrointestinal tract from the oesophagus to the rectum. The greatest levels were found in the duodenum and jejunum, the principal sites for absorption, which were 2·5- and 3-fold respectively above ileal levels.
Quantification of NmU mRNA and peptide contents in the duodenum, jejunum and ileum during postnatal development of the rat showed message and peptide levels to be greater in the maturing rat than in neonates. Message levels in the duodenum, jejunum and ileum showed 14-, 7- and 4-fold increases respectively between 1 and 56 days after birth, whilst the corresponding peptide levels in the duodenum, jejunum and ileum showed 33-, 14- and 25-fold increases respectively.
Food deprivation caused a small, but significant, decrease in message levels in the jejunum and colon, but there was no change in the duodenum or ileum. This shows that the presence of food has little effect on NmU mRNA levels in the gut.
